Zurich Cantonal Bank
PGNX

Zurich Cantonal Bank’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Zurich Cantonal Bank’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4,790
Closed -$18K – 2651
2020
Q1 		$18K Hold
4,790
– – ﹤0.01% 2372
2019
Q4 		$24K Hold
4,790
– – ﹤0.01% 2466
2019
Q3 		$24K Hold
4,790
– – ﹤0.01% 2403
2019
Q2 		$30K Hold
4,790
– – ﹤0.01% 2324
2019
Q1 		$22K Hold
4,790
– – ﹤0.01% 2393
2018
Q4 		$20K Hold
4,790
– – ﹤0.01% 2453
2018
Q3 		$30K Buy
4,790
+2,514
+110% +$19.3K ﹤0.01% 2378
2018
Q2 		$18K Hold
2,276
– – ﹤0.01% 2442
2018
Q1 		$17K Hold
2,276
– – ﹤0.01% 2446
2017
Q4 		$14K Hold
2,276
– – ﹤0.01% 2468
2017
Q3 		$17K Hold
2,276
– – ﹤0.01% 2317
2017
Q2 		$15K Hold
2,276
– – ﹤0.01% 2347
2017
Q1 		$21K Hold
2,276
– – ﹤0.01% 2293
2016
Q4 		$20K Buy
2,276
+606
+36% +$4.48K ﹤0.01% 2279
2016
Q3 		$11K Hold
1,670
– – ﹤0.01% 2401
2016
Q2 		$7K Hold
1,670
– – ﹤0.01% 2468
2016
Q1 		$7K Hold
1,670
– – ﹤0.01% 2474
2015
Q4 		$10K Hold
1,670
– – ﹤0.01% 2400
2015
Q3 		$10K Buy
+1,670
New +$12.8K ﹤0.01% 2042

Other funds holding PGNX

ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

Zurich Cantonal Bank's PGNX Position: Q2 2020 in Review

Zurich Cantonal Bank sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 4,790 shares — an estimated $18K sold.

Zurich Cantonal Bank first reported a position in PGNX in Q3 2015 and held it in 19 quarters. The position peaked at $30K in Q2 2019. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

  • Zurich Cantonal Bank reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
  • Zurich Cantonal Bank sold 4,790 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $18K.
  • Zurich Cantonal Bank first reported a position in Progenics Pharmaceuticals Inc in Q3 2015 and held it in 19 quarters.
  • Zurich Cantonal Bank's Progenics Pharmaceuticals Inc position peaked at $30K in Q2 2019.
  • 3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on Zurich Cantonal Bank's 13F filing for Q2 2020, filed 28 Jul 2020.